MiniMed Group, Inc. (MMED)

Revenue

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Jul 31, 2026	Apr 24, 2026	Apr 25, 2025	Apr 26, 2024	Apr 28, 2023
Pumps Revenue	560.00M	546.00M	541.00M
Consumables Revenue	983.00M	956.00M	854.00M
Continuous Glucose Monitoring (CGM) Revenue	1.60B	1.55B	1.31B
Other Segment Revenue	49.00M	46.00M	6.00M
Revenue (Other)	29.00M	1.00M	1.00M
Revenue (Total)	3.22B	3.10B	2.72B

Revenue by Geography

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Jul 31, 2026	Apr 24, 2026	Apr 25, 2025	Apr 26, 2024	Apr 28, 2023
United States Revenue	932.00M	917.00M	903.00M
International Revenue	2.26B	2.19B	1.81B
Revenue (Other)	29.00M	-	-
Revenue (Total)	3.22B	3.10B	2.72B

Key Performance Indicators

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Apr 24, 2026	Apr 25, 2025	Apr 26, 2024	Apr 28, 2023
US - Organic Revenue Growth	1.50%	8.40%
International - Organic Revenue Growth	11.20%	13.10%
Total Organic Revenue Growth	8.00%	11.50%

Data Source: Fiscal.ai Last updated: Sep 8, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 12, 2026

Data Sources Report a data error